1. Impaired response rates, but satisfying protection rates to influenza vaccination in dialysis patients
- Author
-
Guus F. Rimmelzwaan, N.P.J Vogtländer, R.M Valentijn, A.D.M.E. Osterhaus, A Brown, and Virology
- Subjects
Male ,Hemagglutination Inhibition Tests ,medicine.medical_specialty ,Immunization, Secondary ,Antibodies, Viral ,medicine.disease_cause ,SDG 3 - Good Health and Well-being ,Renal Dialysis ,Internal medicine ,Influenza, Human ,Influenza A virus ,medicine ,Humans ,Renal Insufficiency ,Aged ,Aged, 80 and over ,Hemagglutination assay ,General Veterinary ,General Immunology and Microbiology ,biology ,business.industry ,Vaccination ,Public Health, Environmental and Occupational Health ,Renal disorders [UMCN 5.4] ,Influenza B virus ,Titer ,Infectious Diseases ,Immunization ,Influenza Vaccines ,Immunology ,biology.protein ,Molecular Medicine ,Female ,Viral disease ,Antibody ,business - Abstract
Item does not contain fulltext Dialysis patients show impaired responses to several vaccines. Limited recent data are available on influenza vaccination in these patients. In the 1998-1999 influenza season, 44 dialysis patients received a standard trivalent vaccination followed by a booster two months later. The serum antibody responses in these patients were compared with those found in healthy subjects. A fourfold rise in serum hemagglutination inhibition titre was achieved in 23-58% of all patients. Protective titres were reached in 53-93% of the patients. Since protective antibody titers can be induced, it is recommended to vaccinate dialysis patients annually against influenza.
- Published
- 2004